Regulatory Cell Populations in Relapsing-Remitting Multiple Sclerosis (RRMS) Patients: Effect of Disease Activity and Treatment Regimens-Reference-Cited by-同舟云学术

Regulatory Cell Populations in Relapsing-Remitting Multiple Sclerosis (RRMS) Patients: Effect of Disease Activity and Treatment Regimens

Published:2016-08-25 Issue:9 Volume:17 Page:1398
ISSN:1422-0067
Container-title:International Journal of Molecular Sciences
language:en
Short-container-title:IJMS

Author:

Rodi Maria,Dimisianos Nikolaos,de Lastic Anne-Lise,Sakellaraki Panagiota,Deraos George,Matsoukas John,Papathanasopoulos Panagiotis,Mouzaki Athanasia^ORCID

Publisher

MDPI AG

Subject

Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis

Link

http://www.mdpi.com/1422-0067/17/9/1398/pdf

Reference51 articles.

1. Multiple sclerosis

2. MHC transmission: Insights into gender bias in MS susceptibility

3. Defining the clinical course of multiple sclerosis: Results of an international survey

4. Immunotherapy for Multiple Sclerosis: Basic Insights for New Clinical Strategies

5. Multiple Sclerosis — The Plaque and Its Pathogenesis

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Myelin Oligodendrocyte Glycoprotein (MOG)35–55 Mannan Conjugate Induces Human T-Cell Tolerance and Can Be Used as a Personalized Therapy for Multiple Sclerosis;International Journal of Molecular Sciences;2024-05-31

2. Enhanced Therapeutic Effects of Human Mesenchymal stem Cells Transduced with Secreted Klotho in a Murine Experimental Autoimmune Encephalomyelitis Model;Molecular Neurobiology;2024-05-10

3. Extracellular Purine Metabolism—Potential Target in Multiple Sclerosis;Molecular Neurobiology;2024-03-18

4. Ozanimod-mediated remission in experimental autoimmune encephalomyelitis is associated with enhanced activity of CNS CD27low/- NK cell subset;Frontiers in Immunology;2024-03-12

5. Current knowledge on multiple sclerosis pathophysiology, disability progression assessment and treatment options, and the role of autologous hematopoietic stem cell transplantation;Autoimmunity Reviews;2024-02